L2P Research Acquires METIS Research Laboratories

Premier Radiology Services Acquires MetisMD

July 9, 2025

Healthcare Services

Premier Radiology Services, a Grovecourt Capital Partners-backed teleradiology platform, has acquired MetisMD, a Chicago-based teleradiology provider with deep expertise in musculoskeletal imaging. The add-on expands Premier's subspecialty coverage and national reach, giving MetisMD access to Premier's administrative infrastructure, technology and broader clinical network; terms were not disclosed.

MLM Medical Labs Acquires MD Biosciences, Inc.

October 27, 2020

Healthcare Services

MLM Medical Labs, a Great Point Partners portfolio company, has acquired MD Biosciences, Inc., an Oakdale, Minnesota-based provider of preclinical, translational and clinical-phase contract research services. The deal expands MLM's U.S. footprint and adds immunohistochemistry, preclinical research and histopathology capabilities to its global laboratory platform as part of an integration with recent U.S. additions such as CirQuest Labs.

TransPerfect Life Sciences Acquires LMK Clinical Research Consulting

December 6, 2021

Healthcare Services

TransPerfect Life Sciences has acquired LMK Clinical Research Consulting, a specialized provider of Trial Master File (TMF) document management, training and consulting services. The acquisition expands TransPerfect's TMF and eTMF capabilities and adds LMK's accredited TMF University training program to TransPerfect's life sciences offerings; financial terms were not disclosed.

Sier Capital Partners and ILS Management Complete Management Buyout of Integrated Laboratory Systems (ILS)

September 14, 2020

Healthcare Services

Sier Capital Partners is supporting the management team of Integrated Laboratory Systems (ILS) in an acquisition of the company. ILS, a Research Triangle Park, North Carolina–based contract research organization that provides pre-clinical toxicology and product safety testing, will leverage Sier’s capital and operating expertise to support future growth.

Fibronostics Acquires Stone Clinical Laboratories

October 27, 2025

Healthcare Services

Fibronostics has completed the acquisition of Stone Clinical Laboratories, LLC, expanding its U.S. laboratory infrastructure to accelerate innovation in non-invasive diagnostics for metabolic and liver diseases (MASH/MASLD). The deal strengthens Fibronostics' R&D and testing capabilities, combining Stone Clinical's laboratory expertise with Fibronostics' proprietary LIVERFASt platform to support biomarker development, clinical validation, and collaborations with biopharma and healthcare partners.

PharmaLegacy Laboratories Acquires San Diego-Based BTS Research

September 16, 2024

Healthcare Services

PharmaLegacy Laboratories has acquired BTS Research, a San Diego-based preclinical contract research organization (CRO), expanding PharmaLegacy's in vitro and in vivo pharmacology and GLP toxicology capabilities. The acquisition gives PharmaLegacy a local presence in San Diego to increase study capacity and support clients across the United States and North America.